Ricky Goldwasser

Q: What is Ricky Goldwasser's success rate?

Ricky Goldwasser currently has a success rate of 94.75424672793095.

Q: What is the average return of Ricky Goldwasser's calls?

Their stock ratings have generated an average return of 16.978755869229474.

Morgan Stanley | Healthcare

Ricky Goldwasser is an analyst from Morgan Stanley specializing in the Healthcare sector. Ranked #1350 out of 4688 analysts, they have issued 13 stock ratings with a success rate of 94.75% and an average return of 16.98%.

With 13 ratings to date, Ricky Goldwasser is beginning to establish credibility in the Healthcare sector. They have achieved a success rate of 94.75% and an average return of 16.98%, highlighting promising potential as their track record develops further.

#1350

Out of 4688

Total Ratings

+94.75%

Success Rate

+16.98%

Average Return

Recent Ratings Analysis

CRL

Buy

Jun 17, 2026

Target

$220.00

Current

$184.79

Performance

—

Ricky Goldwasser rated CRL as Overweight on Jun 17, 2026, setting a price target of 220. Shares have remained stable near 184.79, leaving the 220 target still in play.

CNC

Hold

Jun 04, 2026

Target

$57.00

Current

$61.39

Performance

-2.09%

On Jun 04, 2026, CNC was given a Equal-Weight rating by Ricky Goldwasser, with a target price of 57. Market indecision, reflected in sideways trading near 61.39, supported the cautious call.

DOCS

Buy

May 14, 2026

Target

$35.00

Current

$20.89

Performance

15.99%

DOCS received a Overweight rating from Ricky Goldwasser on May 14, 2026, aiming for 35. Momentum has favored the Buy call, with shares climbing from 20.89 to 20.89, rewarding those who trusted the recommendation.

UNH

Buy

Jan 23, 2026

Target

$409.00

Current

$407.65

Performance

14.42%

On Jan 23, 2026, Ricky Goldwasser published a Overweight outlook on UNH, with a target of 409. Shares gained 14.42%, underscoring the accuracy of the bullish outlook toward 409.

LH

Buy

Jul 25, 2025

Target

$306.00

Current

$264.76

Performance

-0.08%

Ricky Goldwasser on Jul 25, 2025 assigned LH a Overweight rating, with a price target of 306. The recommendation remains pending validation as shares consolidate around 264.76.

ACCD

Hold

Dec 17, 2024

Target

$5.00

Current

$7.02

Performance

106.47%

On Dec 17, 2024, Ricky Goldwasser reaffirmed ACCD with a Equal-Weight rating, targeting 5. Market strength beyond 7.02 went further than the conservative outlook suggested.

Frequency Asked Questions

Who is Ricky Goldwasser?

Ricky Goldwasser is an analyst from Morgan Stanley specializing in the Healthcare sector.

What is Ricky Goldwasser's success rate?

Ricky Goldwasser currently has a success rate of +94.75%.

How many ratings has Ricky Goldwasser issued?

Ricky Goldwasser has issued 13 stock ratings so far.

What is the average return of Ricky Goldwasser's calls?

Their stock ratings have generated an average return of +16.98%.

What is Ricky Goldwasser's ranking?

Ricky Goldwasser is ranked #1350 out of 4688 analysts.

What types of ratings does Ricky Goldwasser give?

Their ratings include Buy, Hold, and Sell recommendations, depending on the stock’s outlook.

How can I follow Ricky Goldwasser?

You can follow Ricky Goldwasser by clicking the "Follow Analyst" button on this page to receive updates on their stock calls.

What is the most recent rating by Ricky Goldwasser?

Their latest rating was a Buy on CRL issued on 2026-06-17.